###begin article-title 0
Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The identification of the HLA class II, insulin (INS), CTLA-4 and PTPN22 genes as determinants of type 1 diabetes (T1D) susceptibility indicates that fine tuning of the immune system is centrally involved in disease development. Some genes have been shown to affect several immune-mediated diseases. Therefore, we tested the hypothesis that alleles of susceptibility genes previously associated with other immune-mediated diseases might perturb immune homeostasis, and hence also associate with predisposition to T1D.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP </italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B</italic>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCRL3</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CFH</italic>
###xml 201 209 201 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC9A3R1</italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
###xml 218 231 218 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1, SPINK5</italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL1RN</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL1RA</italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IBD5</italic>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAG3</italic>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NFKB1</italic>
We resequenced and genotyped tag single nucleotide polymorphisms (SNPs) from two genes, CRP and FCER1B, and genotyped 27 disease-associated polymorphisms from thirteen gene regions, namely FCRL3, CFH, SLC9A3R1, PADI4, RUNX1, SPINK5, IL1RN, IL1RA, CARD15, IBD5-locus (including SLC22A4), LAG3, ADAM33 and NFKB1. These genes have been associated previously with susceptibility to a range of immune-mediated diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Graves' disease (GD), psoriasis, psoriatic arthritis (PA), atopy, asthma, Crohn disease and multiple sclerosis (MS). Our T1D collections are divided into three sample subsets, consisting of set 1 families (up to 754 families), set 2 families (up to 743 families), and a case-control collection (ranging from 1,500 to 4,400 cases and 1,500 to 4,600 controls). Each SNP was genotyped in one or more of these subsets. Our study typically had approximately 80% statistical power for a minor allele frequency (MAF) >5% and odds ratios (OR) of 1.5 with the type 1 error rate, alpha = 0.05.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 79 81 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 297 299 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
We found no evidence of association with T1D at most of the loci studied 0.02 <P < 1.0. Only a SNP in ADAM33, rs2787094, was any evidence of association obtained, P = 0.0004 in set 1 families (relative risk (RR) = 0.78), but further support was not observed in the 4,326 cases and 4,610 controls, P = 0.57 (OR = 1.02).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Polymorphisms in a variety of genes previously associated with immune-mediated disease susceptibility and/or having effects on gene function and the immune system, are unlikely to be affecting T1D susceptibility in a major way, even though some of the genes tested encode proteins of immune pathways that are believed to be central to the development of T1D. We cannot, however, rule out effect sizes smaller than OR 1.5.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS </italic>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4 </italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 282 293 282 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL2R2/CD25 </italic>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS </italic>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
The four susceptibility loci identified so far in T1D, the HLA class II gene complex [1], INS [2], CTLA4 [3] and PTPN22 [4,5] indicate that the regulation of T cell development, activation, expansion and homeostasis is a central component of disease development. A fifth locus, the IL2R2/CD25 region [6] awaits independent replication and fine mapping of the aetiological variant. With the exception of INS [7], these genes contain polymorphisms that are associated with susceptibility to other immune-mediated diseases.
###end p 11
###begin p 12
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4 </italic>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Therefore, we hypothesised that further susceptibility variants for T1D may reside in genes previously associated with other immune-mediated diseases, as prior evidence suggests the presence of shared disease susceptibility genes. For example, in families with T1D, other immune-mediated diseases, such as RA and autoimmune thyroid disease (AITD), occur more frequently than expected by chance, indicative of a partly shared genetic basis [7]. This model has gained significant support recently with the association of the Arg620Trp non-synonymous SNP in the PTPN22 gene, encoding the lymphoid specific phosphatase, LYP; not only with T1D [4] but also with GD, RA and SLE [5,8,9]. Likewise CTLA4 has been associated with T1D, AITD, RA and SLE [3,10].
###end p 12
###begin p 13
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Furthermore, as susceptibility to T1D and other autoimmune diseases is probably directly related to the homeostatic, regulatory state of the immune system, it is possible that variants in immune response genes influence susceptibility to T1D via alteration of networks of immune regulation. For example, the CARD15 gene product, NOD2, influences the development of the adaptive immune response [11,12] and functional variants of the gene predispose to the inflammatory bowel disease (IBD), Crohn disease (Table 1). Both the Th1 and mucosal immune system are thought to be important in T1D aetiology [13].
###end p 13
###begin p 14
Previously associated polymorphisms with other immune-mediated diseases and references.
###end p 14
###begin p 15
MAF: minor allele frequency, SLE: systemic lupus erythematosus, RA: rheumatoid arthritis, GD: Graves' disease, HT: Hashimoto thyroiditis, T1D: type 1 diabetes, CD: Crohn disease, MS: multiple sclerosis, PA: Psoriatic arthritis, OR: odds ratio, 95% CI: 95% confidence intervals, N/A: not available
###end p 15
###begin p 16
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 289 308 289 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-reactive protein </italic>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 396 402 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MS4A2</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDDM4</italic>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 775 792 775 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional File 1</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
The aim of this study was to determine whether previously associated polymorphisms of immune-mediated disease also predispose to T1D. We genotyped a total of 41 polymorphisms, including three microsatellite markers, from 16 genes, shown in Table 1, in large T1D collections. For two genes C-reactive protein (CRP), a marker for inflammation and associated with susceptibility to SLE [14,15], and FCER1B, high-affinity receptor for immunoglobulin E (IgE) (MS4A2), located in the putative T1D locus IDDM4, and associated with atopic illness [16,17], we also carried out a re-sequencing effort, to gain a more comprehensive profile of allelic variation of the genes and their potential association with T1D. Our sample sizes had good statistical power for ORs greater than 1.5 (Additional File 1) [18].
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Subjects
###end title 18
###begin p 19
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 106 111 <span type="species:ncbi:9606">child</span>
###xml 623 635 <span type="species:ncbi:9606">participants</span>
T1D families were white European or of white European descent, with two parents and at least one affected child comprising DNA samples from up to 476 multiplex Diabetes UK Warren 1families [19], 278 multiplex HBDI families [20], 250 simplex Northern Ireland families [21], 260 simplex Norwegian families and 233 simplex Romanian families with inclusion criteria as reported in Vella et al. [22]. The T1D cases [23]and the 1958 BBC controls [24] have been described previously [5]. All DNA samples were collected after approval from the relevant research ethics committees and written informed consent was obtained from the participants. This project has run over a number of years during which samples of cases were still being collected. Consequently, owing to availability of DNA, polymorphisms were genotyped either in "set 1" families (n = 754 UK and USA multiplex families), "set 2" families (n = 743 Norwegian, Romanian and Northern Irish simplex families) and/or a British case-control collection consisting of between approximately 1,500 and 4,400 cases and 1,500 and 4,600 controls.
###end p 19
###begin title 20
SNP identification and genotyping
###end title 20
###begin p 21
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP </italic>
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B </italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
CRP (EMBL Accession number AL445528) and FCER1B (AP001181) were annotated locally, importing Ensembl information into a temporary ACeDB database as described previously [25]. After confirmation of gene structures by BLAST analysis, these were re-extracted in GFF format and submitted to T1Dbase [26].
###end p 21
###begin p 22
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP </italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B </italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
Direct sequencing of nested PCR products from 32 T1D individuals was carried out for all exons of CRP and 3 kb 5' and 3' of the gene, using Applied Biosystems 3700 capillary sequencer. Polymorphisms were identified using the Staden Package and loaded into T1Dbase. FCER1B was also sequenced, as for CRP, in 96 T1D individuals for 2 kb 5' and 3 kb 3' of the gene and all exons, except exon 6, were successfully sequenced.
###end p 22
###begin p 23
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
SNPs were genotyped using either TaqMan MGB chemistry (Applied Biosystems), Invader Biplex assay (Third Wave Technologies, Madison) [3] or PCR RFLP. The microsatellites were genotyped on an ABI3700 using fluorescent primers. All genotyping data were double scored to minimize error.
###end p 23
###begin p 24
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Family studies of variants with a MAF less than 5% may be compromised by apparent under transmission of alleles resulting from undetected genotyping errors [27]. To evaluate potential genotyping errors we genotyped a large selection of samples from three SNPs: SNP8 (rs2066844), SNP12 (rs2066845), SNP13 (ss28514842), twice, using two different methods, either TaqMan, Invader or PCR RFLP. The concordance rate between the methods was >99.2%.
###end p 24
###begin title 25
Statistical analyses
###end title 25
###begin p 26
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STATA </italic>
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 85 94 85 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Genassoc </italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">htSNP2 </italic>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 295 297 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1225 1226 1225 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1314 1315 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
All statistical analyses were performed within STATA [28] making specific use of the Genassoc and htSNP2 packages for association and tag SNP selection, available from [29]. All genotyping data of unaffected parents and controls were assessed for, and found to be in Hardy-Weinberg equilibrium (P > 0.05). Associations of the SNPs and microsatellites were tested by the Transmission/disequilibrium test in the families. Allelic and genotypic relative risks were calculated using pseudo-controls and cases with conditional logistic regression [30]. In order to minimise any confounding due to variation in allele frequencies across Great Britain [31], case-control data were stratified by broad geographical region within the logistic regression model used to calculate ORs and test associations. Both genotypic and allelic effects were allowed for by modelling loci as three-level, 2 degrees of freedom (2 df), categorical variables corresponding to a model assuming no particular mode of inheritance and continuous (1 df) variables equating to a multiplicative model. Where a difference was found, by a likelihood ratio test, between the multiplicative model and a model assuming no particular mode of inheritance, the 2 df P-value is reported. The tag SNPs were analysed by use of a multivariate test statistic [6,32].
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP </italic>
###xml 12 18 12 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B</italic>
###xml 175 176 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 176 178 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 186 188 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 224 227 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
###xml 255 272 253 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">Additional File 2</xref>
###xml 275 277 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 356 358 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 511 513 509 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 557 561 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP </italic>
###xml 626 630 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP </italic>
###xml 658 660 656 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">n </sub>
###xml 693 694 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 699 716 697 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">Additional file 2</xref>
###xml 797 799 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
For CRP and FCER1B, we resequenced and followed a tag selection approach, selecting tags that capture the variation of the remaining common SNPs (MAF >/= 0.05) with a minimum R2 of 0.8 [32]. Nineteen SNPs were identified in CRP, five of which were novel (Additional File 2) [26] and seven tag SNPs were selected and genotyped in set 1 families (multilocus P = 0.49). We also genotyped the tag SNPs in the case-control collection (1,607 cases and 1,636 controls) and found no support for association (multilocus P = 0.42), indicating that common variants of CRP are unlikely to influence T1D susceptibility in a major way. The CRP intronic microsatellite (GT)n polymorphism (ss28514831) (Table 1 and Additional file 2) was also genotyped in set 1 and 2 families but showed no association with T1D (P = 0.90).
###end p 28
###begin p 29
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B</italic>
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDDM4 </italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 175 192 175 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">Additional File 3</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 421 423 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 513 515 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 709 716 709 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B </italic>
###xml 773 775 773 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 788 795 788 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B </italic>
###xml 918 920 918 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
On resequencing FCER1B, which is located in the putative diabetes-susceptibility region IDDM4 [33], we identified 34 SNPs, 17 of which were novel, and selected five tag SNPs (Additional File 3) [26]. We were unable to detect the non-synonymous SNP in exon 7, Gly237Glu, in 96 DNA samples, that has previously been associated with atopic asthma [16]. We initially genotyped the five tag SNPs in set 1 families (multilocus P = 0.085), and then followed this result up in set 2 families giving a combined multilocus P = 0.070 (adjusted for two-stage design). In 1,600 cases and 1,636 controls we obtained P = 0.24, and the combination of the multilocus family and case-control results indicated that variants of FCER1B are unlikely to play a major role in T1D susceptibility (P = 0.23). The FCER1B intronic microsatellite polymorphism (ss28514807) also showed no evidence of association with T1D in set 1 and 2 families (P = 0.65).
###end p 29
###begin p 30
###xml 15 50 15 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCRL3, CFH, SLC9A3R1, PADI4, RUNX1 </italic>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPINK5 </italic>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCRL3 </italic>
###xml 189 191 189 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 216 223 216 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPINK5 </italic>
###xml 224 226 224 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 244 246 244 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCRL3 </italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 380 402 380 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL1RN, IL1RA, IGR2198 </italic>
###xml 410 417 410 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 491 493 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 519 527 519 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4 </italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAG3 </italic>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
Five SNPs from FCRL3, CFH, SLC9A3R1, PADI4, RUNX1 and six SNPs from SPINK5 were genotyped in set 1 families and a minimum of 1,500 cases and 1,500 controls (Table 2). All except FCRL3 (TDT P = 0.04) and one locus in SPINK5 (P = 0.03), showed a P value of > 0.05. However, we did not obtain any further evidence of association of FCRL3 in 1,896 cases and 2,020 controls (Table 2). IL1RN, IL1RA, IGR2198 and the CARD15 SNPs 8, 12 and 13 were genotyped in sets 1 and 2 families, and all showed P > 0.10 (Table 3). The two SLC22A4 SNPs and the single LAG3 SNP were genotyped in a minimum of 3,290 cases and 3,549 controls and showed no evidence of association with T1D (Table 3).
###end p 30
###begin p 31
Association analyses in type 1 diabetes families and case-control sample sets for immune-mediated disease associated polymorphisms.
###end p 31
###begin p 32
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
MAF: Minor allele frequency, T: transmitted, NT: not transmitted, TDT: transmission/disequilibrium test P value, RR: relative risk, 95% CI: 95% confidence intervals, OR: odds ratio N: number.
###end p 32
###begin p 33
Association analyses in type 1 diabetes families and case-control sample sets for rheumatoid arthritis, inflammatory bowl disease and multiple sclerosis associated polymorphisms.
###end p 33
###begin p 34
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
MAF: Minor allele frequency, T: transmitted, NT: not transmitted, TDT: transmission/disequilibrium test P value, RR: relative risk, 95% CI: 95% confidence intervals, OR: odds ratio, N: number, n/a: not attempted
###end p 34
###begin p 35
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 440 442 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 480 482 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 510 511 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 516 517 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 529 536 527 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
###xml 559 561 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 633 637 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 645 648 643 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6 </sup>
###xml 826 830 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 843 844 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
As a potential atopy/asthma susceptibility locus, ADAM33 was considered as a candidate gene for T1D because atopic illness and T1D have been inversely associated [34]. No functional candidate SNPs in ADAM33 have been identified, but it is plausible that the SNPs in introns or the 3' region are located in regulatory sequences and thus may affect transcriptional efficiency or transcript stability [35]. We genotyped six SNPs that showed a P </= 0.03 in asthma case-control data [35] in set 1 families (Tables 1 and 4). One SNP, ADAM33 V4 (rs2787094), showed P = 0.0004 (RR = 0.78, 95% CI = 0.67-0.89) initially in 754 families, and P = 4.4 x 10-6 (RR = 0.77, 95% CI = 0.69-0.86) when genotyped in the additional set 2 families. However, we did not obtain additional support for association in 4,326 cases and 4,610 controls (P = 0.57) (Table 4).
###end p 35
###begin p 36
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
Association analyses in type 1 diabetes families and case-control sample sets for ADAM33 SNPs
###end p 36
###begin p 37
###xml 105 107 105 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
MAF: minor allele frequency. T: transmitted. NT: not transmitted. TDT: transmission/disequilibrium test. P value. RR: relative risk. 95% CI: 95% confidence intervals. OR: odd ratios. N: number. n/a: not attempted.
###end p 37
###begin p 38
###xml 54 56 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 116 118 116 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
* Two degree of freedom GTRR (genotype relative risk) P value is reported as its significantly different to the TDT P value.
###end p 38
###begin p 39
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 78 82 78 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TDT </sub>
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 49 54 <span type="species:ncbi:9606">child</span>
** In set 1 and 2 families (1075(571/737) parent-child trios) for ADAM33 V4, PTDT = 4.43 x 10-6, with allelic RR = 0.77 [0.69-0.86] and genotype relative risks: G/G 1.00 [ref], G/C 0.80 [0.70-0.91], C/C 0.54 [0.40-0.73].
###end p 39
###begin p 40
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NFKB1 </italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Finally, we genotyped the NFKB1 dinucleotide repeat (CA) microsatellite polymorphism, which has been associated with T1D [36], albeit inconsistently [37] (Table 1). In our set 1 families, we failed to find any evidence for an association with T1D (P = 0.68).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 383 385 383 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4 </italic>
###xml 688 695 688 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 848 849 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
Co-localization and overlapping of genetic loci in autoimmune diseases suggests that in some cases, common biological pathways may be involved in the aetiology of T1D and other clinically distinct immune-mediated diseases. In this study we examined 16 genes implicated in autoimmune and other immune-mediated diseases and report that none of the variants tested, consistently showed P values of less than 0.05 in association tests with T1D. Our data indicate that, although common immune-mediated disease loci are present in the genome, there are disease genes that are distinct to certain diseases. Indeed, the known T1D susceptibility loci follow this observation: while both CTLA4 and PTPN22 loci are associated with several autoimmune diseases [3,38], the insulin VNTR locus is likely to be T1D-specific rather than a general autoimmune locus [7].
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 720 721 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 842 847 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4</italic>
###xml 996 997 992 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
The possibility remains that some of the investigated genes and variants are associated with T1D, albeit with weak genetic effects, such as with ORs of less than 1.3, for which the sample size employed in our study does not provide sufficient statistical power. Even a case-control sample of 8,000 cases and 8,000 controls would only have 48% statistical power at a type 1 error rate alpha of 0.001 for a disease variant with a MAF of 0.10 and OR of 1.15. As genotyping costs decrease, it will be necessary to test the variants in larger sample sets than reported here, because the identification of genetic effects with ORs in the 1.15-1.25 range can be instrumental in the understanding of the disease process of T1D [3]. For example, we note that an observed genetic effect of OR 1.15, such as that exerted by the T1D susceptibility locus CTLA4, does not reflect the importance of the biological effect contributed by the locus through the protein(s) it encodes and the pathways it regulates [3].
###end p 44
###begin p 45
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 272 274 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Lack of association with variants tested here may also be partly due to false positive results obtained in the reported primary disease association studies. As shown in Table 1, these generally employed small sample sets, which is a common explanation in the reporting of P values that cannot be replicated in independent studies using larger sample sizes [39-42]. Nevertheless, for ORs >1.5 our present study had good statistical power even for alleles at 0.01 frequency.
###end p 45
###begin title 46
Abbreviations
###end title 46
###begin p 47
T1D-type 1 diabetes, SNPs-single nucleotide polymorphisms, MAF-minor allele frequency, OR-odds ratio, RR-relative risk, RA-rheumatoid arthritis, SLE-systemic lupus erythemastosus, GD-Graves' disease, PA-psoriatic arthritis, MS-multiple sclerosis.
###end p 47
###begin title 48
Competing interests
###end title 48
###begin p 49
The author(s) declare that they have no competing interests.
###end p 49
###begin title 50
Authors' contributions
###end title 50
###begin p 51
DJS performed sequencing, SNP genotyping, data analysis and drafted the manuscript. JMMH performed statistical analysis and drafted the manuscript. FP performed sequencing, SNP genotyping and data analysis. LMM performed sequencing, SNP genotyping, data analysis and drafted the manuscript. JDC performed statistical analysis. KH & CL performed sequencing and SNP genotyping. JH, RB, AV & ID performed SNP genotyping and data analysis.
###end p 51
###begin p 52
ACL coordinated annotation of genes. SN prepared DNA samples. NMW managed the data. RCJT coordinated the study. JAT participated in the conception, design and coordination of the study and drafted the manuscript. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Pre-publication history
###end title 53
###begin p 54
The pre-publication history for this paper can be accessed here:
###end p 54
###begin p 55

###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
Additional File 1
###end title 57
###begin p 58
Power calculations for a range of allele frequencies.
###end p 58
###begin p 59
Click here for file
###end p 59
###begin title 60
Additional File 2
###end title 60
###begin p 61
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
Polymorphisms identified in CRP.
###end p 61
###begin p 62
Click here for file
###end p 62
###begin title 63
Additional File 3
###end title 63
###begin p 64
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCER1B</italic>
Polymorphisms identified in FCER1B.
###end p 64
###begin p 65
Click here for file
###end p 65
###begin title 66
Acknowledgements
###end title 66
###begin p 67
###xml 361 369 <span type="species:ncbi:9606">patients</span>
We thank the Juvenile Diabetes Research Foundation, the Wellcome Trust, Diabetes UK and the Medical Research Council, for financial support. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. We gratefully acknowledge the participation of all patients, controls and family members.
###end p 67
###begin p 68
###xml 535 539 <span type="species:ncbi:162683">Mayo</span>
Thanks to Helen Stevens, Gillian Coleman, Sarah Field, Trupti Mistry, Sally Clayton, Matthew Hardy, Pamela Lauder, Meeta Maisuria, William Meadows and Sarah Wood for preparing DNA samples. We acknowledge use of DNA collections from Cristian Guja (Romania), Kjersti Ronningen and Dag Undlien (Norway), David Savage, Chris Patterson and Peter Maxwell (Northern Ireland), David Dunger and Barry Widmer (JDRF/WT Diabetes and Inflammation Laboratory UK GRID Cases) and David Strachan (1958 British Birth Cohort controls). Adrian Vella is a Mayo Foundation scholar, and Kieran Holland received financial support from the Royal College of Pathologists of Australasia.
###end p 68
###begin article-title 69
A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins
###end article-title 69
###begin article-title 70
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDDM2 </italic>
Remapping the insulin gene IDDM2 locus in type 1 diabetes
###end article-title 70
###begin article-title 71
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4 </italic>
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
###end article-title 71
###begin article-title 72
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
###end article-title 72
###begin article-title 73
###xml 79 89 79 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYP/PTPN22</italic>
Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus
###end article-title 73
###begin article-title 74
###xml 47 58 47 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL2RA/CD25 </italic>
Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms
###end article-title 74
###begin article-title 75
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDDM2 </italic>
Evidence for a Type 1 diabetes-specific mechanism for the insulin gene-associated IDDM2 locus rather than a general influence on autoimmunity
###end article-title 75
###begin article-title 76
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) Is Associated with Rheumatoid Arthritis
###end article-title 76
###begin article-title 77
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 89 94 <span type="species:ncbi:9606">Human</span>
Genetic Association of the R620W Polymorphismof Protein Tyrosine Phosphatase PTPN22 with Human SLE
###end article-title 77
###begin article-title 78
CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity?
###end article-title 78
###begin article-title 79
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOD2 </italic>
NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses
###end article-title 79
###begin article-title 80
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract
###end article-title 80
###begin article-title 81
###xml 0 3 <span type="species:ncbi:9913">Cow</span>
Cow's milk and type 1 diabetes: the real debate is about mucosal immune function
###end article-title 81
###begin article-title 82
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus
###end article-title 82
###begin article-title 83
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRP</italic>
Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene
###end article-title 83
###begin article-title 84
Association between atopic asthma and a coding variant of Fc epsilon RI beta in a Japanese population
###end article-title 84
###begin article-title 85
Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor
###end article-title 85
###begin article-title 86
A note on power approximations for the transmission/disequilibrium test
###end article-title 86
###begin article-title 87
The British Diabetic Association - Warren repository
###end article-title 87
###begin article-title 88
Family cell lines available for research
###end article-title 88
###begin article-title 89
Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group
###end article-title 89
###begin article-title 90
Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes
###end article-title 90
###begin article-title 91
T1D Cases
###end article-title 91
###begin article-title 92
1958 Controls
###end article-title 92
###begin article-title 93
Development of an integrated genome informatics, data management and workflow infrastructure: a toolbox for the study of complex disease genetics
###end article-title 93
###begin article-title 94
T1DBase
###end article-title 94
###begin article-title 95
Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test
###end article-title 95
###begin article-title 96
STATA
###end article-title 96
###begin article-title 97
software
###end article-title 97
###begin article-title 98
A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes
###end article-title 98
###begin article-title 99
Population structure, differential bias and genomic control in a large-scale, case-control association study
###end article-title 99
###begin article-title 100
Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power
###end article-title 100
###begin article-title 101
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDDM4</italic>
Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13
###end article-title 101
###begin article-title 102
A meta-analysis of the association between childhood type 1 diabetes and atopic disease
###end article-title 102
###begin article-title 103
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
###end article-title 103
###begin article-title 104
NFkappaB polymorphisms and susceptibility to type 1 diabetes
###end article-title 104
###begin article-title 105
Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families
###end article-title 105
###begin article-title 106
Genetic susceptibility to type 1 diabetes
###end article-title 106
###begin article-title 107
Genome-wide association studies: theoretical and practical concerns
###end article-title 107
###begin article-title 108
Parameters for reliable results in genetic association studies in common disease
###end article-title 108
###begin article-title 109
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
###end article-title 109
###begin article-title 110
Genetic associations in large versus small studies: an empirical assessment
###end article-title 110
###begin article-title 111
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCRL3</italic>
A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities
###end article-title 111
###begin article-title 112
Complement factor H polymorphism in age-related macular degeneration
###end article-title 112
###begin article-title 113
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
###end article-title 113
###begin article-title 114
Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis
###end article-title 114
###begin article-title 115
The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis
###end article-title 115
###begin article-title 116
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1 </italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis
###end article-title 116
###begin article-title 117
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OCTN </italic>
Functional variants of OCTN cation transporter genes are associated with Crohn disease
###end article-title 117
###begin article-title 118
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
###end article-title 118
###begin article-title 119
Gene polymorphism in Netherton and common atopic disease
###end article-title 119
###begin article-title 120
Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample
###end article-title 120
###begin article-title 121
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAG3 </italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL7R</italic>
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis
###end article-title 121
###begin article-title 122
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
###end article-title 122
###begin article-title 123
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOD2 </italic>
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
###end article-title 123
###begin article-title 124
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15</italic>
CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis
###end article-title 124
###begin article-title 125
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
CARD15 mutations in Blau syndrome
###end article-title 125
###begin article-title 126
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1 </italic>
###xml 46 55 46 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC9A3R1 </italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT9 </italic>
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
###end article-title 126
###begin article-title 127
Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations
###end article-title 127

